Do manualized psychosocial interventions help reduce relapse among alcohol-dependent adults treated with naltrexone or placebo? A meta-analysis

American Journal on Addictions

Volumn 21, Issue 6, 2012, Pages 501-507

  Agosti, Vito ^a   Nunes, Edward V ^b   O'Shea, Donna ^b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NALTREXONE; PLACEBO;

ADULT; ALCOHOLISM; ARTICLE; COGNITIVE THERAPY; FEMALE; HUMAN; MALE; META ANALYSIS; MORBIDITY; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; RECURRENCE RISK; RELAPSE;

ADULT; ALCOHOLISM; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; RECURRENCE;

EID: 84867886535     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2012.00270.x     Document Type: Article

References (36)

1. Grant BF, Dawson DA, Stinson FS, et al., The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002. Drug Alcohol Depend. 2004; 74: 223-234.
2. Rice DP, Kelman S, Miller LS,. Estimates of economic costs of alcohol and drug abuse and mental illness, 1985 and 1988. Public Health Rep. 1991; 106: 280-292.
3. Center for Disease Prevention. Available at: http://www.cdc.gov/nchs/ factats/alcohol/htm. Accessed February 7, 2005.
4. Schuckit M,. Drug and Alcohol Abuse: A Clinical Guide to Diagnosis and Treatment, 6th edn. New York: Sringer-Verlag; 2006.
5. Anton RF,. New methodologies for pharmacological treatment trials for alcohol dependence. Alcohol Clin Exp Res. 1996; 20: 3A-9A.
6. McLellan AT, Luborsky L, Woody GE, et al., Predicting response to alcohol and drug abuse treatments: Role of psychiatric severity. Arch Gen Psychiatry. 1983; 40: 620-625.
7. Wallace AE, Weeks WB,. Substance abuse intensive outpatient treatment: Does program graduation matter J Subst Abuse Treat. 2004; 27: 27-30.
8. Pettinati HM, Volpicelli JR, Pierce JD, Jr., et al., Improving naltrexone response: An intervention for medical practitioners to enhance medication compliance in alcohol dependent patients. J Addict Dis. 2000; 19: 71-83.
9. McCaul ME, Petry NM,. The role of psychosocial treatments in pharmacotherapy for alcoholism. Am J Addict. 2003; 12 Suppl 1: S41-52.
10. Anton RF, O'Malley SS, Ciraulo DA, et al., Combined pharmacotherapies and behavioral interventions for alcohol dependence-the COMBINE study: A randomized controlled trial. JAMA. 2006; 295: 2003-2017.
11. Matching alcoholism treatments to client heterogeneity: Treatment main effects and matching effects on drinking during treatment. Project MATCH Research Group. J Stud Alcohol. 1998; 59: 631-639.
12. Detsky AS, Naylor CD, O'Rourke K, et al., Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol. 1992; 45: 255-265.
13. American Psychiatric Association. Diagnostic Criteria for Psychiatric Disorders, 4th edn. Washington, DC: American Psychiatric Association; 1994.
14. Bornstein M, Borenstein H,. Comprehensive Meta-Analysis. Englewood, NJ: Biostat Inc.; 1999.
15. Higgins JP, Thompson SG,. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21: 1539-1558.
16. Schulz KF, Chalmers I, Hayes RJ, et al., Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995; 273: 408-412.
17. Anton RF, Moak DH, Latham P, et al., Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence. J Clin Psychopharmacol. 2005; 25: 349-357.
18. Balldin J, Berglund M, Borg S, et al., A 6-month controlled naltrexone study: Combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence. Alcohol Clin Exp Res. 2003; 27: 1142-1149.
19. O'Malley SS, Jaffe AJ, Chang G, et al., Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry. 1992; 49: 881-887.
20. Anton RF, Moak DH, Waid LR, et al., Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: Results of a placebo-controlled trial. Am J Psychiatry. 1999; 156: 1758-1764.
21. Chick J, Anton R, Checinski K, et al., A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol Alcohol. 2000; 35: 587-593.
22. Gastpar M, Bonnet U, Boning J, et al., Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study. J Clin Psychopharmacol. 2002; 22: 592-598.
23. Guardia J, Caso C, Arias F, et al., A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: Results from a multicenter clinical trial. Alcohol Clin Exp Res. 2002; 26: 1381-1387.
24. Huang MC, Chen CH, Yu JM, et al., A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan. Addict Biol. 2005; 10: 289-292.
25. Kiefer F, Jahn H, Tarnaske T, et al., Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: A double-blind, placebo-controlled study. Arch Gen Psychiatry. 2003; 60: 92-99.
26. Kranzler HR, Modesto-Lowe V, Van Kirk J,. Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial. Neuropsychopharmacology. 2000; 22: 493-503.
27. Krystal JH, Cramer JA, Krol WF, et al., Naltrexone in the treatment of alcohol dependence. N Engl J Med. 2001; 345: 1734-1739.
28. Latt NC, Jurd S, Houseman J, et al., Naltrexone in alcohol dependence: A randomised controlled trial of effectiveness in a standard clinical setting. Med J Aust. 2002; 176: 530-534.
29. Mason BJ, Salvato FR, Williams LD, et al., A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence. Arch Gen Psychiatry. 1999; 56: 719-724.
30. Morley KC, Teesson M, Reid SC, et al., Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial. Addiction. 2006; 101: 1451-1462.
31. Oslin D, Liberto JG, O'Brien J, et al., Naltrexone as an adjunctive treatment for older patients with alcohol dependence. Am J Geriatr Psychiatry. 1997; 5: 324-332.
32. Volpicelli JR, Alterman AI, Hayashida M, et al., Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 1992; 49: 876-880.
33. Volpicelli JR, Rhines KC, Rhines JS, et al., Naltrexone and alcohol dependence. Role of subject compliance. Arch Gen Psychiatry. 1997; 54: 737-742.
34. Kranzler HR, Van Kirk J,. Efficacy of naltrexone and acamprosate for alcoholism treatment: A meta-analysis. Alcohol Clin Exp Res. 2001; 25: 1335-1341.
35. Feinn R, Kranzler HR,. Does effect size in naltrexone trials for alcohol dependence differ for single-site vs. multi-center studies Alcohol Clin Exp Res. 2005; 29: 983-988.
36. Dutra L, Stathopoulou G, Basden SL, et al., A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry. 2008; 165: 179-187.